Predictors of 12-Month Outcome in Smokers Who Received Bupropion Sustained-Release for Smoking Cessation

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.3, 2008-01, pp. : 239-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictors of 1-, 6- and 12-month smoking cessation among a community-recruited sample of adult smokers in the United States

By Harte Christopher B. Watts Tyler W. Meston Cindy M.

Journal of Substance Use, Vol. 18, Iss. 5, 2013-10 ,pp. : 405-416

Radcliffe Press

Access to resources Recommend Favorite

Bupropion SR for smoking cessation

By West Robert

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 533-540

Informa Healthcare

Access to resources Recommend Favorite

Predictors of Smoking Cessation Medication Use among Nonobese and Obese Smokers

By Yang Mo Mehta Hemalkumar B. Bhowmik Debajyoti Essien Ekere James Abughosh Susan M.

Substance Use & Misuse, Vol. 49, Iss. 6, 2014-05 ,pp. : 752-761

Informa Healthcare

Access to resources Recommend Favorite

Agitated delirium associated with therapeutic doses of sustained-release bupropion

By Mack Diana

International Journal of Clinical Pharmacy, Vol. 34, Iss. 1, 2012-02 ,pp. : 9-12

Springer Publishing Company

Access to resources Recommend Favorite

Sustained-release (SR) bupropion appears to reduce gambling behaviour in pathological gamblers

Inpharma, Vol. 1, Iss. 1514, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite